.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
Dow
US Army
Cantor Fitzgerald
Queensland Health
Cerilliant
Mallinckrodt
Cipla

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020726

« Back to Dashboard
NDA 020726 describes FEMARA, which is a drug marketed by Novartis Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the FEMARA profile page.

The generic ingredient in FEMARA is letrozole. There are twenty-four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the letrozole profile page.

Summary for NDA: 020726

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details

Pharmacology for NDA: 020726

Mechanism of ActionAromatase Inhibitors

Suppliers and Packaging for NDA: 020726

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FEMARA
letrozole
TABLET;ORAL 020726 NDA Novartis Pharmaceuticals Corporation 0078-0249 0078-0249-15 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0078-0249-15)
FEMARA
letrozole
TABLET;ORAL 020726 NDA Physicians Total Care, Inc. 54868-4151 54868-4151-0 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (54868-4151-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Jul 25, 1997TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020726

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms
FEMARA
letrozole
TABLET;ORAL020726-001Jul 25, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Medtronic
Farmers Insurance
Merck
Daiichi Sankyo
Federal Trade Commission
Chinese Patent Office
Cerilliant
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot